Results 121 to 130 of about 830,895 (193)

Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas. [PDF]

Cancers (Basel)
Irimia R, Piccaluga PP.
europepmc   +1 more source

Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4. [PDF]

J Biomed Sci
Gu Z, Ye F, Luo H, Li X, Gong Y, Mao S, Jia X, Han X, Han B, Fu Y, Cheng X, Li J, Shao Z, Wen P, Hu X, Zhuang Z.   +15 more
europepmc   +1 more source

Acetylation and Histone Deacetylase Inhibitors in Cancer

Cellular Oncology, 2006
Madeleine S. Q. Kortenhorst, Michael A. Carducci, Shabana Shabbeer   +2 more
doaj   +1 more source

Aromatic Amino Acid Hydroxylases as Off-Targets of Histone Deacetylase Inhibitors. [PDF]

ACS Chem Neurosci
Baumann A, Papenkordt N, Robaa D, Szigetvari PD, Vogelmann A, Bracher F, Sippl W, Jung M, Haavik J.   +8 more
europepmc   +1 more source

Central nervous system distributional kinetics of selected histone deacetylase inhibitors. [PDF]

J Pharmacol Exp Ther
Zhang W, Oh JH, Zhang W, Aldrich CC, Sirianni RW, Elmquist WF.   +5 more
europepmc   +1 more source

Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia. [PDF]

Ther Adv Hematol
Xiao T, Chen Z, Xie Y, Yang C, Wu J, Gao L.   +5 more
europepmc   +1 more source

Histone Deacetylase Inhibitors as a Promising Treatment Against Myocardial Infarction: A Systematic Review. [PDF]

J Clin Med
Sanchez-Fernandez E, Guerra-Ojeda S, Suarez A, Serna E, Mauricio MD.   +4 more
europepmc   +1 more source

Natural Compounds and Histone Deacetylase Inhibitors: A Combined Approach Against mCRPC Cells. [PDF]

Biomedicines
Alimudin J, Betts Z, Ozkan AD.
europepmc   +1 more source

New potent N-hydroxycinnamamide-based histone deacetylase inhibitors suppress proliferation and trigger apoptosis in THP-1 leukaemia cells. [PDF]

Arch Pharm (Weinheim)
Onuscakova M, Kauerova T, Fialova E, Pizova H, Garaj V, Kemka M, Frecer V, Kollar P, Bobal P.   +8 more
europepmc   +1 more source

Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer. [PDF]

J Control Release
Li J, Arnold J, Sima M, Al Faruque H, Galang J, Hu-Lieskovan S, Kopeček J, Yang J.   +7 more
europepmc   +1 more source